Novo Nordisk
NVO
#107
Rank
โ‚น15.595 T
Marketcap
โ‚น3,507
Share price
-2.59%
Change (1 day)
-54.53%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): โ‚น1.799 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น47.70 Billion. , an increase over its 2024 earnings that were of โ‚น1.719 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น1.876 T9.13%
2024 โ‚น1.719 T22.84%
2023 โ‚น1.399 T57.81%
2022 โ‚น886.98 B5.24%
2021 โ‚น842.85 B12.38%
2020 โ‚น749.99 B13.11%
2019 โ‚น663.07 B-3.45%
2018 โ‚น686.76 B1.88%
2017 โ‚น674.06 B4.3%
2016 โ‚น646.25 B10.32%
2015 โ‚น585.79 B7.47%
2014 โ‚น545.09 B3.4%
2013 โ‚น527.16 B19.09%
2012 โ‚น442.67 B15.58%
2011 โ‚น383.00 B16.58%
2010 โ‚น328.54 B25.66%
2009 โ‚น261.46 B10.68%
2008 โ‚น236.23 B55.82%
2007 โ‚น151.61 B7.02%
2006 โ‚น141.66 B19.05%
2005 โ‚น118.99 B10.55%
2004 โ‚น107.63 B
2002 โ‚น75.68 B-14.39%
2001 โ‚น88.40 B-52.82%
2000 โ‚น187.35 B250%
1999 โ‚น53.53 B31.21%
1998 โ‚น40.79 B34.31%
1997 โ‚น30.37 B11.46%
1996 โ‚น27.25 B9.03%
1995 โ‚น24.99 B-3.15%
1994 โ‚น25.80 B-0.67%
1993 โ‚น25.97 B45.38%
1992 โ‚น17.86 B-13.81%
1991 โ‚น20.73 B37.12%
1990 โ‚น15.11 B-0.79%
1989 โ‚น15.24 B26.2%
1988 โ‚น12.07 B24.97%
1987 โ‚น9.66 B-0.9%
1986 โ‚น9.75 B-7.78%
1985 โ‚น10.57 B24.87%
1984 โ‚น8.46 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.076 T-42.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.044 T 8.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น826.76 B-55.94%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น729.80 B-61.11%๐Ÿ‡บ๐Ÿ‡ธ USA